RxDoctor Payments Data

Alfred Sommer

Ophthalmology · Baltimore, MDNPI 1730392028

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,929,268 of the $2,929,310 with a category attached, or 100.0%. BD accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2020 at $1,350,774 and has fallen 100.0% since, to $42 in 2025. Among ophthalmology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,929,310in general payments, 2019–2025

Across 6 payments — averaging $488,218 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$2.9M
  • Johnson & Johnson$42

What the payments were for

  • Speaking & faculty fees$2,929,268100%
  • Food & beverage$420%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BD5$2,929,268
Johnson & Johnson1$42

How this compares

$2,929,310 in reported general payments places this provider in the 95th percentile of 493 ophthalmology providers in Maryland.

See all ophthalmology providers in Maryland →

Other ophthalmology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →